Cx Institutional Ligand Pharmaceuticals Inc Transaction History

Cx Institutional

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 18, 2022	SELL	$127.69 - $165.85 $541,405 - $703,204	-4,240 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$102.33 - $144.73 $67,947 - $96,100	664 Added 18.57%	4,240 $591,000
Q2 2021 Aug 04, 2021	BUY	$113.03 - $155.64 $404,195 - $556,568	3,576 New	3,576 $469,000
Q3 2019 Oct 10, 2019	SELL	$86.25 - $120.16 $1,380 - $1,922	-16 Closed	0 $0
Q2 2019 Jul 17, 2019	BUY	$107.38 - $129.34 $1,718 - $2,069	16 New	16 $2,000

275

18.5M

30.8K

5.2K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.95B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Cx Institutional, based on Form 13F filings with the SEC.

Stay updated on Cx Institutional with notifications on news.